Fig. 6: Comparison between control and anti-VEGF treatment of CD8+ effector T-cells, viable and dead cancer cells.
The spatial distribution of CD8+ effector T-cells, viable and dead cancer cells volume fraction for control and anti-VEGF at the end of the simulation.
